AZD3152
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AZD3152, covering 2024-12-27 to 2025-08-15. Get the full timeline:
Most recent: Clinical Trial Update: Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasing Risk of Inadequate Protective Immune Response After Vaccination and Thus Are at High Risk of Developing Severe COVID-19 [Phase 2]